Photothermally Controlled MHC Class I Restricted CD8+T-Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Photothermally Controlled MHC Class I Restricted CD8+T-Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy

Published:2018-03-06 Issue:10 Volume:7 Page:1701439
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Cao Fengqiang¹,Yan Mengmeng¹,Liu Yijia¹,Liu Lanxia¹,Ma Guilei¹^ORCID

Affiliation:

1. The Tianjin Key Laboratory of Biomaterials; Institute of Biomedical Engineering; Peking Union Medical College & Chinese Academy of Medical Sciences; 236# Baidi Road Tianjin 300192 China

Funder

National Natural Science Foundation of China

CAMS Innovation Fund for Medical Sciences

Natural Science Foundation of Tianjin City

Science and Technology Support Program of Tianjin

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/adhm.201701439/fullpdf

Reference41 articles.

1. Vaccines for the 21st century

2. Vaccines for the future: learning from human immunology

3. Vaccine manufacturing: challenges and solutions

4. Therapeutic cancer vaccines

5. License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Light responsive plasmonic nanomaterials applied to cancer phototherapy;Nanophototherapy;2025

2. An optically responsive cancer vaccine for inducing robust anti-tumor immunity by apoptotic body carrying nanoadjuvants;Chemical Engineering Journal;2024-09

3. Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy;Materials Today;2024-09

4. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

5. Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges;International Journal of Nanomedicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3